Dietary prophylaxis as an alternative method for the prevention of the development of insulin resistance;Dietoprofilaktyka jako metoda alternatywna zapobiegania rozwojowi oporności na insulinȩ

Medycyna Weterynaryjna

Volumn 59, Issue 9, 2003, Pages 767-772

  Orzechowski, Arkadiusz ^a,b  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b NONE   (Poland)

Author keywords

Dietetics; Insulin resistance; Oxidative stress; Prophylaxis

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CYSTEINE; GLUTAMINE; GLUTATHIONE; INSULIN; LEUCINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; THIAZOLIDINE DERIVATIVE; THIOCTIC ACID;

AMINO ACID DEFICIENCY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ASSOCIATION; GLUCOSE TOLERANCE TEST; GLUTATHIONE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LOW FAT DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROPHYLAXIS; REVIEW;

EID: 0141425659     PISSN: 00258628     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Baker A. F., Briehl M. M., Dorr R., Powis P.: Decreased antioxidant defence and increased oxidant stress during dexamethasone-induced apoptosis: bcl-2 prevents the loss of antioxidant enzyme activity. Cell Death Diff. 1996, 3, 207-213.
2. Bara-Tana J.: Peroxisome proliferator-activated receptor gamma (PPARgamma) activation and its consequences in humans. Toxicol. Lett. 2001, 120, 9-19.
3. Berger J., Tanen M., Elbrecht A., Hermanowski-Vosatka A., Moller D. E., Wright S. D., Thieringer R.: Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11 beta-hydroxysteroid dehydrogenase type 1 expression and activity. J. Biol. Chem. 2001, 276, 12629-12635.
4. Catani M. V., Rossi A., Costanzo A., Sabatini S., Levrero M., Melino G., Avigliano L.: Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. Biochem. J. 2001, 356, 77-85.
5. Chepda T., Cadau M., Lassabliere F., Reynaud E., Perier C., Frey J., Chamson A.: Synergy between ascorbate and alpha-tocopherol on fibroblasts in culture. Life Sci. 2001, 69, 1587-1596.
6. Cornelius P., Marlowe M., Pekala P. H. J.: Regulation of glucose transport by tumor necrosis factor-alpha in cultured murine 3T3-L1 fibroblasts. J. Trauma 1990, 30, S15-20
7. Danon A.: Redox reactions of regulatory proteins: do kinetics promote specifity? Trends Biochem. Sci. 2002, 26, 197-203.
8. Despres J-P., Marette A.: The metabolic syndrome. Insulin resistance. (Reaven GM, Laws A - ed.), Humana Press Inc., Totowa, NJ, 1999, 51-82.
9. Feichtenhofer S., Fabjan J. S., Abuja P. M.: Ceruloplasmin as low-density lipoprotein oxidase: activation by ascorbate and dehydroascorbate. FEBS Lett. 2001, 501, 42-46.
10. Fukui T., Noma T., Mizushige K., Aki Y., Kimura S., Abe Y.: Dietary troglitazone decreases oxidative stress in early stage type II diabetic rats. Life Sci. 2000, 21, 2043-2049.
11. Grizard J., Dardevet D., Papet I., Mosoni L., Patureau Mirand P., Attaix D.: Nutrient regulation of skeletal muscle protein metabolism in animals. The involvement of hormones and substrates. Nutr. Res. Rev. 1995, 53, 132-156.
12. Houseknecht K. L., Vanden Heuvel J. P., Moya-Camarena S. Y., Portocarrero C. P., Peck L. W., Nickel K. P., Belury M. A.: Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Biophys. Res. Commun. 1998, 244, 678-682.
13. 2+-superoxide dismutase in the liver. Life Sci. 1998, 63, 135-144.
14. Johnston C. S., Cox S. K.: Plasma-saturating intakes of vitamin C confer maximal antioxidant protection to plasma. J. Am. Coll. Nutr. 2001, 20, 623-627.
15. Johnston C. S., Meyer C. G., Srilakshmi J. C.: Vitamin C elevates red blood cell glutathione in healthy adults. Am. J. Clin. Nutr. 1993, 58, 103-105.
16. Kausch C., Krutzfeldt J., Witke A., Rettig A., Bachmann O., Rett K., Matthaei S., Machicao F., Haring H-U., Stumvoll M.: Effects of troglitazone on cellular differentiation, insulin signalling, and glucose metabolism in cultured human skeletal muscle cells. Biochem. Biophys. Res. Commun. 2001, 280, 664-674.
17. Khanna S., Roy S., Packer L., Sen C. K.: Cytokine-induced glucose uptake in skeletal muscle: redox regulation and the role of α-lipoic acid. Am. J. Physiol. 276 (Regulatory Integrative Comp. Physiol. 45), 1999, R1327-1333.
18. Klipstein-Grobush K., Breeijen J. H., Grobbee D. E., Boeing H., Hofman A., Witteman J. C. M.: Dietary antioxidants and peripheral arterial disease. Am. J. Epidemiol. 2001, 154, 145-149.
19. Kontush A., Mann U., Arlt S., Ujeyl A., Luhrs C., Muller-Thomsen T., Beisiegel U.: Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Rad. Biol. Med. 2001, 31, 345-354.
20. Mohan I. K., Das U. N.: Prevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutr. 2001, 17, 126-151.
21. Mudaliar S., Henry R. R.: New oral therapies for type 2 diabetes mellitus: the glitazones of insulin sensitizers. Annu. Rev. Med. 2001, 52, 239-257.
22. O'Brien M. L., Twaroski T. P., Cunningham M. L., Glauert H. P., Spear B. T.: Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters. Toxicological Sci. 2001, 60, 271-278.
23. Ohtsuka A., Ohtani T., Horiguchi H., Kojima H., Hayashi K. J.: Vitamin E reduces glucocorticoid-induced growth inhibition and lipid peroxidation in rats. Nutr. Sci. Vitaminol. (Tokyo) 1998, 44, 237-247.
24. Orzechowski A., Łokociejewska M., Muras P., Hocquette J-F.: Preconditioning with millimolar concentrations of vitamin C or N-acetylcysteine protects L6 muscle cells insulin-stimulated viability and DNA synthesis under oxidative stress. Life Sci. 2002, 71, 1793-1808.
25. Orzechowski A., Ostaszewski P., Brodnicka A., Wilczak J., Jank M., Bałasińska B., Grzelkowska K., Płoszaj T., Olczak J., Mrówczyńska A.: Excess of glucocorticoids impairs whole body antioxidant status in young rats. Relation to the effect of dexamethasone in soleus muscle and spleen. Horm. Metab. Res. 2000, 32, 174-180.
26. Perez-Ruiz T., Martinez-Loranzo C., Tomas V., Fenol J.: Fluorometric determination of total ascorbic acid by stopped-flow mixing technique. Analyst 2001, 126, 1436-1429.
27. Rolandsson O., Hagg E., Nilsson Mo, Hallmans G., Mincheva-Nillson G., Lernmark A.: Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population. J. Internat Med. 2001, 249, 279-288.
28. Rosen P., Nawroth P. P., King G., Moller W., Trischler H. J., Packer L.: The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 2001, 17, 189-212.
29. Seven A., Tasan E., Inci F., Hatemi H., Burcak G.: Biochemical evaluation of oxidative stress in propylthiouracil treated hyperthyroid patients. Effects of vitamin C supplementation. Clin. Chem. Lab. Med. 1998, 36, 767-770.
30. Siman C. M., Eriksson U. J.: Vitamin C supplementation of the maternal diet reduces the rate of malfomation in the offspring of diabetic rats. Diabetologia 1997, 40, 1416-1424.
31. Smith U., Carvalho E., Mosialou E., Beguinot F., Formisano P., Rondinone C.: PKB inhibition prevents the stimulatory effect of insulin on glucose transport and protein translocation but not the antilipolytic effect in rat adipocytes. Biochem. Biophys. Res. Commun. 2000, 268, 315-320.
32. Smith U., Gogg S., Johannsson A., Olausson T., Rotter V., Svalstedt B.: Thiazolidinediones (PPARγ agonists) but not PPARα agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes. FASEB J. 2001, 15, 215-220.
33. Tordjman K., Bernal-Mizrachi C., Zemany L., Wenig S., Feng C., Zhang F., Leone T. C., Coleman T., Kelly D. P., Semenkovich C. F.: PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J. Clin. Invest. 2001, 107, 1025-1034.
34. Way J. M., Harrington W. W., Brown K. K., Gottschalk W. K., Sundseth S. S., Mansfield T. A., Ramachandran R. K., Willson T. M., Kliewer S. A.: Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinol 2001, 141, 1269-1277.
35. Wen Y., Cooke T., Feely J.: The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation. Br. J. Clin. Pharmacol. 1997, 44, 94-97.
36. Wright J. R. Jr., Fraser R. B., Kapoor S., Cook H. W.: Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in native and cyclosporin-treated low-responder murine strains. Acta Diabetol. 1995, 32, 125-130.